SectorBiological Technology
Established Date--
Listing Date02/07/2015
ExchangeNASDAQ Stock Exchange
Full-time Employees6135
Fiscal Year Ends31/12
Security TypeCommon stock
Office address13011 McCallen Pass, Building A Suite 100, Austin, TX 78753
Business
IntroductionNatera, Inc., was incorporated in Delaware in January 2007. The company is a diagnostic company with proprietary molecular and bioinformatics technology that is being applied to transform disease management on a global scale. The company's cell-free DNA (CFDNA) technology combines novel molecular analysis methods that reliably measure many information regions across the genome from samples ranging from small to individual cells, as well as statistical algorithms that combine data provided by the wider scientific community to identify genetic variants covering a wide range of serious diseases with high precision and coverage. The company's goal is to make personalized genetic testing and diagnosis part of the standard of care that protects health and inform earlier and more targeted interventions to help achieve longer, healthier lives.
